Daxor Announces the Purchase of a BVA-100 by Northshore University Hospital, Manhasset
New York, NY, December 7, 2004--Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed purchase agreement from the North Shore University Hospital of Manhasset, NY. North Shore University Hospital is one of the clinical hubs of the North Shore-LIJ Health System, headquartered in Great Neck, NY. The Health System serves Long Island, Queens and Staten Island. The North Shore-LIJ system is comprised of 16 hospitals, hospice and home care services, a major medical research institute and many other health-related facilities.

North Shore University Hospital has 731 beds and is an academic medical center campus for New York University School of Medicine. It offers the most advanced care in all medical disciplines, including open-heart surgery for both adults and children. Its Cardiology Center is a national demonstration site for advanced equipment and procedures. The hospital also excels in intensive care for medical, surgical, newborns, pediatric patients. The Don Monti Cancer Center has a full-service bone marrow transplant unit. There is a 30-bed designated unit for HIV/AIDS care and the institution is a designated Level 1 Trauma Center.

As the largest employer on Long Island and one of the largest healthcare systems in the United States, the North Shore-LIJ Health System is "Setting New Standards in Healthcare" every day. The Sandra Atlas Bass Cardiology Center is a national demonstration site for advanced equipment and procedures. The Don Monti Cancer Center cares for more cancer patients than all other Long Island hospitals combined. The Schwartz Ambulatory Surgery Center performs 10,000 surgical procedures annually. The hospital was recognized in the 2004 U.S. News & World Report Ranks as One of the 50 Best Hospitals Nationwide for Cardiac Care.

Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit, and measures blood volume to within a 98% accuracy. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.

For more infomation, please contact:
Stephen Feldschuh
Vice President of Operations
Diane Meegan
Investor Relations